IMA vs SPCE · rev $9.2M vs rev $7.0M
ImageneBio, Inc. (IMA) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
IMA currently screens at market cap $64.7M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the IMA and SPCE stock pages for the full models.
Not investment advice.